Ovoca Bio Plc

Our management team

Kirill Golovanov

 

Chief Executive Office 
Kirill Golovanov

Mr. Golovanov joined Ovoca as a corporate advisor in 2007 and moved to be the manager of the Company’s Russia representative office in 2009. He was appointed as Chief Executive Officer of Ovoca in May 2012. During his time at Ovoca he played a major role in the development and subsequent sale of the Goltsovoye silver deposit and the Olcha gold deposit. He has extensive experience in the development of venture businesses in Russia, as well as working experience at leading Russian enterprises, such as Gazprombank and Vneshekonombank. Mr. Golovanov holds a JD, Moscow State Law Academy, Moscow, Russia and an MBA from Duke University’s Fuqua School of Business, NC, USA. He also holds a Russian qualification certificate corresponding to the position of a head, or a controller, or a specialist in an organisation which carries out securities management and manage investment funds, unit investment funds and non-governmental pension funds. Mr. Golovanov is fluent i Russian and English.

Svetlana Radchenko

 

Chief Financial Officer  
Svetlana Radchenko

Mrs. Svetlana Radchenko joined Ovoca as a financial advisor in 2007 and was appointed Chief Financial Officer in 2009. Mrs. Svetlana Radchenko has more than 23 years’ experience in financial management of both Russian and international companies across a range of sectors including banks, pharmaceutical, and commodities. Mrs. Radchenko has a Doctorate in Finance from St. Petersburg State University, Russia, an MA in Finance from Moscow State University, Russia and an ACCA Advanced Diploma in Accounting and Business.  Mrs. Radchenko is fluent in Russian and English.

 

Daniil Nemenov

 

General director, Ivix Ltd. 
Daniil Nemenov

 

Mr. Nemenov joined Ivix Ltd. in 2014 as Medical Director. Mr. Nemenov is managing Libicore clinical development program, and is involved in Business Development. Mr. Nemenov holds an MD from Moscow Medical Academy, and has experience as medical practitioner and as pharmaceutical clinical development professional. Since 2011 he was clinical/medical director at several biotech startups in Russia. Between 2008 and 2011 he worked in clinical research operations at Novartis Pharma. From 2005 to 2008 Mr. Nemenov was involved in performing clinical trials at several  hospitals in Russia, acting as clinical investigator. Mr. Nemenov is fluent in Russian and English.

Mikhail Lomonosov

 

Chief Scientific Officer,
Ivix Ltd. 
Mikhail Lomonosov

Mr. Lomonosov is managing Research and Manufacturing in the company, and involved with international IP and Business Development. Mikhail has a broad Experience in International scientific research. He performed part of his PhD thesis at Danish Cancer Society in Copenhagen, Denmark, followed by postdoctoral training at the International Centre for Genetic Engineering and Biotechnology in Trieste, Italy. From 2000 to 2009 he conducted research in the Department of Oncology and Department of Pathology in the University of Cambridge, UK. He was also involved in founding and development of several startups in UK before joining Ivix Ltd in 2013. Mr. Lomonosov is fluent in Russian and English.